Covered recipient · General Payments record
AMANDA M ROUBLICK
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,657.30
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.45 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $82.25 | 4 |
| PFIZER INC. | $62.93 | 3 |
| Daiichi Sankyo Inc. | $46.07 | 2 |
| GENZYME CORPORATION | $44.82 | 2 |
| SANOFI PASTEUR INC. | $25.14 | 1 |
| Grifols USA, LLC | $19.05 | 1 |
| ABBVIE INC. | $18.98 | 1 |
| Cumberland Pharmaceuticals, Inc. | $16.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.98 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105980739 | CMS |
| Cumberland Pharmaceuticals, Inc. | $16.21 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146403298 | CMS |
| Daiichi Sankyo Inc. | $21.99 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089476177 | CMS |
| Daiichi Sankyo Inc. | $24.08 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089476175 | CMS |
| GENZYME CORPORATION | $29.47 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139838603 | CMS |
| GENZYME CORPORATION | $15.35 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139838609 | CMS |
| Grifols USA, LLC | $19.05 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124718390 | CMS |
| Merck Sharp & Dohme LLC | $16.77 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141952663 | CMS |
| Merck Sharp & Dohme LLC | $24.47 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141558533 | CMS |
| Merck Sharp & Dohme LLC | $16.03 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141822907 | CMS |
| Merck Sharp & Dohme LLC | $24.98 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141908300 | CMS |
| PFIZER INC. | $18.48 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132011794 | CMS |
| PFIZER INC. | $21.55 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131762146 | CMS |
| PFIZER INC. | $22.90 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131879465 | CMS |
| SANOFI PASTEUR INC. | $25.14 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128748525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.